New Direction for Research: Microbiota
(August 20, 2019) A new direction for research in ovarian cancer was brought to light last month thanks to a study published in Lancet Oncology. Researchers led by Dr. Nuno … Continued
News
OCRA Funded Research Reveals New Drug Therapy Combination
(July 26, 2019) OCRA grantee Michael Yaffe, MD, PhD, led a study published earlier this month in Cell Systems which found success targeting cancer cells by combining two existing classes … Continued
Watch OCRA’s 2019 National Conference Presentations on Live Stream
Couldn’t make it to our National Conference? Watch our expert presentations LIVE! For the first time, we live streamed all general sessions, so you can watch as our expert speakers present … Continued
Combination Niraparib plus Pembrolizumab Shows Promise
(June 18, 2019) Results of new trials, funded in part by OCRA though the Ovarian Cancer Dream Team and published in JAMA Oncology, show that combination niraparib plus pembrolizumab therapy … Continued
OCRA and American Cancer Society Launch New Ovarian Cancer Research Collaboration
Four multidisciplinary teams to be funded to study survivorship (June 13, 2019) In a new collaboration, the American Cancer Society and Ovarian Cancer Research Alliance have joined forces to fund … Continued
Highlights from American Society of Clinical Oncology’s Annual Meeting
OCRA is back from the American Society of Clinical Oncology’s annual meeting in Chicago, where doctors and researchers met to discuss the latest in the care of women with ovarian … Continued
OCRA Funded Research Identifies Genes Associated with Increased Risk of Ovarian Cancer
(May 21, 2019) Earlier this month, Nature Genetics published a study, in part funded by OCRA, that found 34 genes were connected to women developing the earliest stages of ovarian … Continued
Hope on the Horizon for Ovarian Cancer – The Washington Post
(May 20, 2019) University of Chicago gynecologic oncologist Nita K. Lee wants the next generation of doctors to know that the story of ovarian cancer is changing for the better … Continued
Highlights from 2019 SGO Annual Meeting on Women’s Cancer
(April 3, 2019) In March, ovarian cancer researchers, clinicians and advocates gathered to attend the much-anticipated Society of Gynecologic Oncology’s (SGO) 50th Annual Meeting on Women’s Cancer, to discuss the … Continued
National Comprehensive Cancer Network Updates Guidelines
(March 26, 2019) The NCCN, or the National Comprehensive Cancer Network, recently updated its clinical guidelines for the treatment of ovarian cancers. The guidelines, a summary of which can be … Continued
OCRA Funded Study Aims to Increase Efficacy of PARP Inhibitors
(March 20, 2019) The Ovarian Cancer Dream Team, funded in part by OCRA, recently completed a Phase 1b Trial, which combined a PARP inhibitor with an HRR (homologous recombination repair) … Continued
Action Alert: Tell Congress to Increase OCRP Funding
(March 19, 2019) Congress is considering a $15 million increase for OCRP funding. Urge YOUR Representative to sign the letter to help push this funding through. Deadline is March 25th! … Continued